CS
ZEAL

Credit Suisse’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Credit Suisse’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-285
Closed -$4K – 4508
2022
Q2 		$4K Buy
+285
New +$3.66K ﹤0.01% 3769

Other funds holding ZEAL

TF
TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return

Credit Suisse's ZEAL Position: Q3 2022 in Review

Credit Suisse sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 285 shares — an estimated $4K sold.

Credit Suisse first reported a position in ZEAL in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.

  • Credit Suisse reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 285 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $4K.
  • Credit Suisse first reported a position in Zealand Pharma A/S American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's Zealand Pharma A/S American Depositary Shares position peaked at $4K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.